AI-Powered Blood Test To Outsmart Multi-cancer
Make Cancer Screening Convenient and Effective With a Single Blood Draw
Advanced Technology
Uses cutting-edge DNA sequencing and AI technologies to screen for presence of cancer DNA in your blood (circulating tumor DNA).
Accuracy in confirming
the absence of cancer when the result was negative, based on a study involving 9,024 people 2.
(1) According to WHO, American Cancer Society 2024 and USPSTF recommendations.
(2) Nguyen, et. al. (2025) Prospective validation study: a non-invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults. BMC Med 23, 90. https://doi.org/10.1186/s12916-025-03929-y
7/10
currently have no standard-of-care screening program available detected by SPOT-MAS1.
Find out:
Who is SPOT-MAS for?
The SPOT-MAS test is recommended for use in adults with elevated risk of cancer, such as those aged 40 years or older, those who carry genetic mutations, or those with unhealthy habits like smoking, drinking alcohol, getting hepatitis B, C. SPOT-MAS is not recommended for pregnant women or patients undergoing cancer treatment, or those with the history of bone marrow transplant, blood transfusion within 3 months.
Patients
Patient Guiding Handbook 5.17 MB 757 downloads
Spot early signals of 10 common and aggressive cancers using next generation of ctDNA...Find out:
Healthcare Providers
